Symbol="TCBPW"
AssetType="Common Stock"
Name="TC BioPharm (Holdings) plc Warrants"
Description="TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, is focused on developing immunotherapy products based on its gamma delta allogeneic T-cell platform. The company is headquartered in Motherwell, the United Kingdom."
CIK="1872812"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="MAXIM 1, 2 PARKLANDS WAY, HOLYTOWN, GB"
FiscalYearEnd="December"
LatestQuarter="2021-12-31"
MarketCapitalization="None"
EBITDA="-5733499"
PERatio="None"
PEGRatio="None"
BookValue="-0.651"
DividendPerShare="0"
DividendYield="0"
EPS="-0.754"
RevenuePerShareTTM="0.102"
ProfitMargin="0"
OperatingMarginTTM="-3.319"
ReturnOnAssetsTTM="0"
ReturnOnEquityTTM="0"
RevenueTTM="1978700"
GrossProfitTTM="0"
DilutedEPSTTM="-0.754"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="None"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="-"
EVToRevenue="-"
EVToEBITDA="-"
Beta="None"
num_52WeekHigh="7.5"
num_52WeekLow="0.0171"
num_50DayMovingAverage="0"
num_200DayMovingAverage="0"
SharesOutstanding="0"
DividendDate="None"
ExDividendDate="None"
symbol="TCBPW"
open="0.03"
high="0.04"
low="0.03"
price="0.04"
volume="34371.00"
latest_trading_day="2023-08-11"
previous_close="0.03"
change="0.00"
change_percent="10.3080%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="90"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="10"
Volume_recent_avg="17485"
Change_recent_avg="0.01"
Delta_recent_avg="0.01"
Variance_recent_avg="0.01"
Change_ratio_recent_avg="-2.05"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="10"
Aroon_momentum_negative="90"
image_negative_thumbnail_id_1="142"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0034.jpeg"
image_negative_thumbnail_id_2="159"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0017.jpeg"
image_neutral_thumbnail_id_1="572"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0027.jpeg"
image_neutral_thumbnail_id_2="580"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0019.jpeg"
image_positive_thumbnail_id_1="994"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0156.jpeg"
image_positive_thumbnail_id_2="998"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0160.jpeg"
image_professor_thumbnail_id_1="1175"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
image_professor_thumbnail_id_2="1185"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
